Qube Research & Technologies (QRT)
VVOS icon

Qube Research & Technologies (QRT)’s Vivos Therapeutics VVOS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$38 – 4784
2023
Q3 		$38 Buy
+8
New +$60 ﹤0.01% 3840

Other funds holding VVOS

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VVOS Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Vivos Therapeutics (VVOS) in Q4 2023, closing a stake of 8 shares — an estimated $38 sold.

Qube Research & Technologies (QRT) first reported a position in VVOS in Q3 2023 and held it in 1 quarter. The position peaked at $38 in Q3 2023. 18 funds tracked by Wall St. Rank hold VVOS as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Vivos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 8 Vivos Therapeutics shares in Q4 2023, an estimated $38.
  • Qube Research & Technologies (QRT) first reported a position in Vivos Therapeutics in Q3 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Vivos Therapeutics position peaked at $38 in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.